Tech Company Financing Transactions
Quanta Dialysis Technologies Funding Round
On 11/18/2024, Quanta Dialysis Technologies landed $60 million in Series E investment from b2venture, Glenview Capital Management and Novo Holdings.
Transaction Overview
Company Name
Announced On
11/18/2024
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series E
Investors
Proceeds Purpose
The company intends to use the funds to expand its commercial presence in the US and continue to invest in innovation within the sector.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
The Woods, Haywood Road
Warwick, CV34 5AH
UK
Warwick, CV34 5AH
UK
Phone
Website
Email Address
Overview
Dialysis is a life-sustaining treatment. But currently, it's largely based on an antiquated care model that requires intensive time, bulky equipment, and rigid demands on patients and providers. At Quanta, we believe there is a better way. Quanta offers the kind of flexible kidney care solutions that put you in control. Our Quanta Dialysis System was developed with the user in mind.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alejandro Galindo
Chief Financial Officer
Jonathan Isenburg
Chief Medical Officer
Paul Komenda
VP - General Counsel
George Maynard
VP - Manufacturing
Suresh Persaud
VP - Product Management
Mark Prockter
Browse more venture capital transactions:
Prev: 11/18/2024: Zenflow venture capital transaction
Next: 11/18/2024: HealthKart venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs